Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 327 clinical trials
None
A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients

-associated mortality. Liver diseases associated with HBV are affected by the antiviral drugs used for HIV infection (toxic side effects), the current immune function in the patient, by improvements

hepatitis
immunodeficiency
tenofovir
antiviral drugs
  • 6 views
  • 07 Nov, 2020
  • 1 location
None
Breakthrough CMV Lung Transplant -Multicentre

called CMV mismatch. For these lung transplant patients 6 to 12 months of prophylaxis with an antiviral called Valganciclovir is recommended. This antiviral can cause side effects like bone marrow

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
TRACERx Renal CAPTURE Sub-study

antiviral response in a pan-tumour immune monitoring study

primary cancer
cancer
metastasectomy
cancer diagnosis
nephrectomy
  • 13 views
  • 24 Jan, 2021
  • 4 locations
None
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients

antiviral medication is administered for a period of several months or preemption in which close monitoring of CMV viral load from the peripheral blood is performed and treatment is initiated when CMV is

organ transplantation
liver transplant
antiviral drugs
solid organ transplant
  • 15 views
  • 25 Jan, 2021
  • 11 locations
None
Study of Tenofovir Alafenamide Fumarate Tablets (TAF) in Blocking Mother-to-child Transmission of Hepatitis B Virus

women whose HBsAg and HBeAg are positive are included in the study.Eligible hepatitis B pregnant women are given TAF antiviral therapy at 24-28 weeks of gestation to block mother-to-child transmission

  • 0 views
  • 23 Jan, 2021
  • 1 location
None
Study of Hepatitis Eradication Receiving Protease Inhibitor Administration

This is a prospective, non-blinded cohort study that will assess the safety, tolerability, and antiviral efficacy of glecaprevir/pibrentasivir therapy given post-discharge to HCV-negative

  • 0 views
  • 25 Mar, 2021
  • 1 location
None
Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

Portal hypertension (PH) is one of the key drivers of clinical deteoration in patients with liver cirrhosis. It has been demonstrated that antiviral therapy in patients with chronic hepatitis C

antiviral therapy
cirrhosis
hepatitis
hypertension
  • 0 views
  • 05 Sep, 2021
  • 1 location
None
Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients

results obtained will allow us to gain insight on the need of antiviral treatment, on the strategy for complications surveillance, on how to adjust the immunosuppressant therapy and on the level of care

cough
covid-19
dyspnea
antiviral drugs
respiratory infection
  • 0 views
  • 02 Nov, 2021
  • 1 location
None
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure

oral antiviral treatment in HBV-related ACLF. However, no conclusion on which nucleoside analogue is the most satisfactory drug for the treatment of HBV-related liver failure has not been reached yet

nucleoside analogue
hepatic failure
hbv dna
tenofovir
acute on chronic liver failure
  • 6 views
  • 22 Jan, 2021
  • 7 locations
None
Safety of Remdesivir Treatment in COVID-19 Patients Requiring Hemodialysis

The FDA approved the antiviral drug remdesivir for use in adults for the treatment of COVID-19 requiring hospitalization. There are only limited data about the safety of the drug in

  • 0 views
  • 30 Apr, 2021
  • 1 location